Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2017 (2017), Article ID 1278268, 12 pages
https://doi.org/10.1155/2017/1278268
Review Article

Desmoplastic Small Round Blue Cell Tumor: A Review of Treatment and Potential Therapeutic Genomic Alterations

1Department of Hematology/Oncology, Kymera Independent Physicians, Carlsbad, NM, USA
2Division of Internal Medicine, Department of Hematology/Oncology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA
3Department of Surgery, University of New Mexico, Albuquerque, NM, USA
4Caris Life Sciences, Phoenix, AZ, USA
5All Saints University School of Medicine, Roseau, Dominica
6Acharya Shri Chander College of Medical Sciences and Hospital, Jammu, India
7Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
8Department of Pediatric Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Correspondence should be addressed to Ajaz Bulbul; moc.liamg@lublubzaja

Received 9 June 2017; Accepted 17 September 2017; Published 1 November 2017

Academic Editor: Chandrajit Premanand Raut

Copyright © 2017 Ajaz Bulbul et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Honore, K. Amroun, L. Vilcot et al., “Abdominal desmoplastic small round cell tumor: multimodal treatment combining chemotherapy, surgery, and radiotherapy is the best option,” Annals of Surgical Oncology, vol. 22, no. 4, pp. 1073–1079, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Dufresne, P. Cassier, L. Couraud et al., “Desmoplastic small round cell tumor: current management and recent findings,” Sarcoma, vol. 2012, Article ID 714986, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. W. L. Gerald and J. Rosai, “Case 2 desmoplastic small cell tumor with divergent differentiation,” Pediatric Pathology, vol. 9, no. 2, pp. 177–183, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. W. L. Gerald and J. Rosai, “Desmoplastic small cell tumor with multi-phenotypic differentiation,” Zentralblatt für Pathologie, vol. 139, no. 2, pp. 141–151, 1993. View at Google Scholar
  5. M. E. Lae, P. C. Roche, L. Jin, R. V. Lloyd, and A. G. Nascimento, “Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors,” American Journal of Surgical Pathology, vol. 26, no. 7, pp. 823–835, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. R. E. Schwarz, W. L. Gerald, B. H. Kushner, D. G. Coit, M. F. Brennan, and M. P. La Quaglia, “Desmoplastic small round cell tumors: prognostic indicators and results of surgical management,” Annals of Surgical Oncology, vol. 5, no. 5, pp. 416–422, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Hayes-Jordan and P. M. Anderson, “The diagnosis and management of desmoplastic small round cell tumor: a review,” Current Opinion in Oncology, vol. 23, no. 4, pp. 385–389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. E. A. Albano and J. Kanter, “Images in clinical medicine. Sister Mary Joseph’s nodule,” New England Journal of Medicine, vol. 352, no. 18, p. 1913, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. W. L. Gerald, H. K. Miller, H. Battifora, M. Miettinen, E. G. Silva, and J. Rosai, “Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals,” American Journal of Surgical Pathology, vol. 15, no. 6, pp. 499–513, 1991. View at Publisher · View at Google Scholar
  10. C. R. Antonescu, W. L. Gerald, M. S. Magid, and M. Ladanyi, “Molecular variants of the EWS-WT1 gene fusion in desmoplastic small round cell tumor,” Diagnostic Molecular Pathology, vol. 7, no. 1, pp. 24–28, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. W. L. Gerald, J. Rosai, and M. Ladanyi, “Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 4, pp. 1028–1032, 1995. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Liu, M. M. Nau, J. C. Yeh, C. J. Allegra, E. Chu, and J. J. Wright, “Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors,” Clinical Cancer Research, vol. 6, no. 9, pp. 3522–3529, 2000. View at Google Scholar
  13. S. B. Lee, K. A. Kolquist, K. Nichols et al., “The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour,” Nature Genetics, vol. 17, no. 3, pp. 309–313, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. B. S. Worley, L. T. van den Broeke, T. J. Goletz et al., “Antigenicity of fusion proteins from sarcoma-associated chromosomal translocations,” Cancer Research, vol. 61, no. 18, pp. 6868–6875, 2001. View at Google Scholar
  15. J. Chen, Z. Wu, B. Sun et al., “Intra-abdominal desmoplastic small round cell tumors: CT and FDG-PET/CT findings with histopathological association,” Oncology Letters, vol. 11, no. 5, pp. 3298–3302, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Thomas, G. Rajeswaran, K. Thway, C. Benson, K. Shahabuddin, and E. Moskovic, “Desmoplastic small round cell tumour: the radiological, pathological and clinical features,” Insights into Imaging, vol. 4, no. 1, pp. 111–118, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. B. Kis, K. N. O’Regan, A. Agoston, O. Javery, J. Jagannathan, and N. H. Ramaiya, “Imaging of desmoplastic small round cell tumour in adults,” British Journal of Radiology, vol. 85, no. 1010, pp. 187–192, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Chouli, J. Viala, C. Dromain, K. Fizazi, P. Duvillard, and D. Vanel, “Intra-abdominal desmoplastic small round cell tumors: CT findings and clinicopathological correlations in 13 cases,” European Journal of Radiology, vol. 54, no. 3, pp. 438–442, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. R. A. Vicens, M. Patnana, O. Le et al., “Multimodality imaging of common and uncommon peritoneal diseases: a review for radiologists,” Abdominal Imaging, vol. 40, no. 2, pp. 436–456, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Volker, T. Denecke, I. Steffen et al., “Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial,” Journal of Clinical Oncology, vol. 25, no. 34, pp. 5435–5441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Ostermeier, M. B. McCarville, F. Navid, S. E. Snyder, and B. L. Shulkin, “FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow up,” Pediatric Radiology, vol. 45, no. 9, pp. 1308–1315, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. V. C. Arora, A. P. Price, S. Fleming et al., “Characteristic imaging features of desmoplastic small round cell tumour,” Pediatric Radiology, vol. 43, no. 1, pp. 93–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. N. P. Caraway, C. V. Fanning, R. J. Amato, N. G. Ordóñez, and R. L. Katz, “Fine-needle aspiration of intra-abdominal desmoplastic small cell tumor,” Diagnostic Cytopathology, vol. 9, no. 4, pp. 465–470, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Klijanienko, P. Colin, J. Couturier et al., “Fine-needle aspiration in desmoplastic small round cell tumor: a report of 10 new tumors in 8 patients with clinicopathological and molecular correlations with review of the literature,” Cancer Cytopathology, vol. 122, no. 5, pp. 386–393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. J. P. Crapanzano, M. Cardillo, O. Lin, and M. F. Zakowski, “Cytology of desmoplastic small round cell tumor,” Cancer, vol. 96, no. 1, pp. 21–31, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Pohar-Marinsek, “Difficulties in diagnosing small round cell tumours of childhood from fine needle aspiration cytology samples,” Cytopathology, vol. 19, no. 2, pp. 67–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Gautam, R. Srinivasan, A. Rajwanshi, D. Bansal, and R. K. Marwaha, “Comparative evaluation of flow-cytometric immunophenotyping and immunocytochemistry in the categorization of malignant small round cell tumors in fine-needle aspiration cytologic specimens,” Cancer, vol. 114, no. 6, pp. 494–503, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. R. L. Harmon and P. H. Sugarbaker, “Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer,” International Seminars in Surgical Oncology, vol. 2, no. 1, p. 3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Hayes-Jordan, H. Green, N. Fitzgerald, L. Xiao, and P. Anderson, “Novel treatment for desmoplastic small round cell tumor: hyperthermic intraperitoneal perfusion,” Journal of Pediatric Surgery, vol. 45, no. 5, pp. 1000–1006, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. S. M. Schuetze, “Utility of positron emission tomography in sarcomas,” Current Opinion in Oncology, vol. 18, no. 4, pp. 369–373, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. A. W. Rachfal, M. H. Luquette, and D. R. Brigstock, “Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour,” Journal of Clinical Pathology, vol. 57, no. 4, pp. 422–425, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Scharnhorst, A. J. van der Eb, and A. G. Jochemsen, “WT1 proteins: functions in growth and differentiation,” Gene, vol. 273, no. 2, pp. 141–161, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. J. C. Wong, S. B. Lee, M. D. Bell et al., “Induction of the interleukin-2/15 receptor beta-chain by the EWS-WT1 translocation product,” Oncogene, vol. 21, no. 13, pp. 2009–2019, 2002. View at Publisher · View at Google Scholar
  34. E. Ito, R. Honma, J. Imai et al., “A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing’s sarcoma-Wilms’ tumor 1 fusion protein of desmoplastic small round-cell tumor,” American Journal of Pathology, vol. 163, no. 6, pp. 2165–2172, 2003. View at Publisher · View at Google Scholar
  35. T. A. Natoli, J. A. Alberta, A. Bortvin et al., “Wt1 functions in the development of germ cells in addition to somatic cell lineages of the testis,” Developmental Biology, vol. 268, no. 2, pp. 429–440, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. J. F. Armstrong, K. Pritchard-Jones, W. A. Bickmore, N. D. Hastie, and J. B. Bard, “The expression of the Wilms’ tumour gene, WT1, in the developing mammalian embryo,” Mechanisms of Development, vol. 40, no. 1-2, pp. 85–97, 1993. View at Publisher · View at Google Scholar · View at Scopus
  37. A. K. Charles, S. Mall, J. Watson, and P. J. Berry, “Expression of the Wilms’ tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study,” Molecular Pathology, vol. 50, no. 3, pp. 138–144, 1997. View at Publisher · View at Google Scholar
  38. A. J. Murphy, K. Bishop, C. Pereira et al., “A new molecular variant of desmoplastic small round cell tumor: significance of WT1 immunostaining in this entity,” Human Pathology, vol. 39, no. 12, pp. 1763–1770, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Bandopadhayay, A. M. Jabbour, C. Riffkin et al., “The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts,” BMC Cancer, vol. 13, no. 1, p. 585, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. A. A. Sandberg and J. A. Bridge, “Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. desmoplastic small round-cell tumors,” Cancer Genetics and Cytogenetics, vol. 138, no. 1, pp. 1–10, 2002. View at Publisher · View at Google Scholar
  41. S. Movva, W. Wen, W. Chen et al., “Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets,” Oncotarget, vol. 6, no. 14, pp. 12234–12247, 2015. View at Publisher · View at Google Scholar
  42. P. J. Zhang, J. R. Goldblum, B. R. Pawel, C. Fisher, T. L. Pasha, and F. G. Barr, “Immunophenotype of desmoplastic small round cell tumors as detected in cases with EWS-WT1 gene fusion product,” Modern Pathology, vol. 16, no. 3, pp. 229–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Xiu, A. Bulbul, and S. Rashad, “Potential therapeutic genomic alterations in desmoplastic small round blue cell tumor,” Journal of Clinical Oncology, vol. 35, no. 15, p. 11066, 2017. View at Publisher · View at Google Scholar
  44. S. Hirota, K. Isozaki, Y. Moriyama et al., “Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors,” Science, vol. 279, no. 5350, pp. 577–580, 1998. View at Publisher · View at Google Scholar · View at Scopus
  45. J. R. Kim, Y. J. Moon, K. S. Kwon et al., “Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas,” PLoS One, vol. 8, no. 12, p. e82870, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Paoluzzi, M. V. Ghesani, A. Cacavio, A. Rapkiewicz, and G. Rosen, “Anti-PD1 therapy with nivolumab in sarcoma,” Journal of Clinical Oncology, vol. 34, no. 15, p. 11047, 2016. View at Publisher · View at Google Scholar
  47. M. A. Burgess, J. Crowley, D. K. Reinke et al., “SARC 028: a phase II study of the anti-PD1 antibody pembrolizumab (P) in patients (Pts) with advanced sarcomas,” Journal of Clinical Oncology, vol. 33, no. 15, p. TPS10578, 2015. View at Publisher · View at Google Scholar
  48. B. Timmermann, M. Kerick, C. Roehr et al., “Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis,” PLoS One, vol. 5, no. 12, p. e15661, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. D. T. Le, J. N. Uram, H. Wang et al., “PD-1 blockade in tumors with mismatch-repair deficiency,” New England Journal of Medicine, vol. 372, no. 26, pp. 2509–2520, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. R. J. Motzer, B. Escudier, D. F. McDermott et al., “Nivolumab versus everolimus in advanced renal-cell carcinoma,” New England Journal of Medicine, vol. 373, no. 19, pp. 1803–1813, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Burgess and H. Tawbi, “Immunotherapeutic approaches to sarcoma,” Current Treatment Options in Oncology, vol. 16, no. 6, p. 26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Champiat, C. Ferté, S. Lebel-Binay, A. Eggermont, and J. C. Soria, “Exomics and immunogenics: bridging mutational load and immune checkpoints efficacy,” Oncoimmunology, vol. 3, no. 1, p. e27817, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Mellado-Lagarde, S. M. Federico, C. Tinkle, A. Shelat, and E. Stewart, “PARP inhibitor combination therapy in desmoplastic small round cell tumors,” Journal of Clinical Oncology, vol. 35, no. 15, p. e23212, 2017. View at Publisher · View at Google Scholar
  54. A. Hayes-Jordan, H. L. Green, H. Lin et al., “Complete cytoreduction and HIPEC improves survival in desmoplastic small round cell tumor,” Annals of Surgical Oncology, vol. 21, no. 1, pp. 220–224, 2014. View at Publisher · View at Google Scholar · View at Scopus
  55. B. H. Kushner, M. P. LaQuaglia, N. Wollner et al., “Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy,” Journal of Clinical Oncology, vol. 14, no. 5, pp. 1526–1531, 1996. View at Publisher · View at Google Scholar
  56. D. R. Lal, W. T. Su, S. L. Wolden, K. C. Loh, S. Modak, and M. P. La Quaglia, “Results of multimodal treatment for desmoplastic small round cell tumors,” Journal of Pediatric Surgery, vol. 40, no. 1, pp. 251–255, 2005. View at Publisher · View at Google Scholar · View at Scopus
  57. K. A. Goodman, S. L. Wolden, M. P. La Quaglia, and B. H. Kushner, “Whole abdominopelvic radiotherapy for desmoplastic small round-cell tumor,” International Journal of Radiation Oncology, Biology, Physics, vol. 54, no. 1, pp. 170–176, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. C. C. Pinnix, H. P. Fontanilla, A. Hayes-Jordan et al., “Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery,” International Journal of Radiation Oncology, Biology, Physics, vol. 83, no. 1, pp. 317–326, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. V. Subbiah, R. Murthy, and P. M. Anderson, “[90Y]Yttrium microspheres radioembolotherapy in desmoplastic small round cell tumor hepatic metastases,” Journal of Clinical Oncology, vol. 29, no. 11, pp. e292–e294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Mazuryk, A. H. Paterson, W. Temple, K. Arthur, T. Crabtree, and D. A. Stewart, “Benefit of aggressive multimodality therapy with autologous stem cell support for intra-abdominal desmoplastic small round cell tumor,” Bone Marrow Transplantation, vol. 21, no. 9, pp. 961–963, 1998. View at Publisher · View at Google Scholar
  61. G. Bisogno, A. Ferrari, A. Rosolen et al., “Sequential intensified chemotherapy with stem cell rescue for children and adolescents with desmoplastic small round-cell tumor,” Bone Marrow Transplantation, vol. 45, no. 5, pp. 907–911, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Hayes-Jordan, M. P. LaQuaglia, and S. Modak, “Management of desmoplastic small round cell tumor,” Seminars in Pediatric Surgery, vol. 25, no. 5, pp. 299–304, 2016. View at Publisher · View at Google Scholar · View at Scopus
  63. F. Farhat, S. Culine, C. Lhomme et al., “Desmoplastic small round cell tumors: results of a four-drug chemotherapy regimen in five adult patients,” Cancer, vol. 77, no. 7, pp. 1363–1366, 1996. View at Publisher · View at Google Scholar
  64. D. A. Casey, L. H. Wexler, M. S. Merchant et al., “Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience,” Pediatric Blood & Cancer, vol. 53, no. 6, pp. 1029–1034, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Grill, B. Geoerger, L. Gesner et al., “Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study,” Neuro-Oncology, vol. 15, no. 9, pp. 1236–1243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. B. H. Kushner, P. A. Meyers, W. L. Gerald et al., “Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing’s sarcoma, in children and young adults,” Journal of Clinical Oncology, vol. 13, no. 11, pp. 2796–2804, 1995. View at Publisher · View at Google Scholar
  67. B. H. Kushner, M. P. LaQuaglia, M. A. Bonilla et al., “Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age,” Journal of Clinical Oncology, vol. 12, no. 12, pp. 2607–2613, 1994. View at Publisher · View at Google Scholar
  68. T. Watanabe, S. Miyamoto, K. Kitagori et al., “A case of long-term survival of metastatic desmoplastic small round cell tumor treated with multimodal therapy,” Oncology Letters, vol. 3, no. 1, pp. 30–34, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. J. E. Visvader and G. J. Lindeman, “Cancer stem cells in solid tumours: accumulating evidence and unresolved questions,” Nature Reviews Cancer, vol. 8, no. 10, pp. 755–768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. M. L. Suva, N. Riggi, J. C. Stehle et al., “Identification of cancer stem cells in Ewing’s sarcoma,” Cancer Research, vol. 69, no. 5, pp. 1776–1781, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. H. E. Grier, M. D. Krailo, N. J. Tarbell et al., “Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone,” New England Journal of Medicine, vol. 348, no. 8, pp. 694–701, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Werner, G. Idelman, M. Rubinstein, P. Pattee, S. R. Nagalla, and C. T. Roberts Jr., “A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene,” Cancer Letters, vol. 247, no. 1, pp. 84–90, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. D. Aguilera, A. Hayes-Jordan, P. Anderson, S. Woo, M. Pearson, and H. Green, “Outpatient and home chemotherapy with novel local control strategies in desmoplastic small round cell tumor,” Sarcoma, vol. 2008, Article ID 261589, 9 pages, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. O. M. Tirado, S. Mateo-Lozano, and V. Notario, “Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax :Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity,” Oncogene, vol. 24, no. 20, pp. 3348–3357, 2005. View at Publisher · View at Google Scholar · View at Scopus
  75. A. M. Thijs, W. T. van der Graaf, and C. M. van Herpen, “Temsirolimus for metastatic desmoplastic small round cell tumor,” Pediatric Blood & Cancer, vol. 55, no. 7, pp. 1431-1432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Dimitrakopoulou-Strauss, P. Hohenberger, P. Strobel, A. Marx, and L. G. Strauss, “A recent application of fluoro-18-deoxyglucose positron emission tomography, treatment monitoring with a mammalian target of rapamycin inhibitor: an example of a patient with a desmoplastic small round cell tumor,” Hellenic Journal of Nuclear Medicine, vol. 10, no. 2, pp. 77–79, 2007. View at Google Scholar
  77. A. M. Frezza, C. Benson, I. R. Judson et al., “Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience,” Clinical Sarcoma Research, vol. 4, p. 7, 2014. View at Publisher · View at Google Scholar
  78. W. D. Tap, R. L. Jones, B. A. Van Tine et al., “Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial,” Lancet, vol. 388, no. 10043, pp. 488–497, 2016. View at Publisher · View at Google Scholar · View at Scopus
  79. W. T. van der Graaf, J. Y. Blay, S. P. Chawla et al., “Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial,” Lancet, vol. 379, no. 9829, pp. 1879–1886, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. P. Schoffski, S. Chawla, R. G. Maki et al., “Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial,” Lancet, vol. 387, no. 10028, pp. 1629–1637, 2016. View at Publisher · View at Google Scholar · View at Scopus
  81. G. D. Demetri, M. von Mehren, R. L. Jones et al., “Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized multicenter clinical trial,” Journal of Clinical Oncology, vol. 34, no. 8, pp. 786–793, 2016. View at Publisher · View at Google Scholar · View at Scopus
  82. P. Schoffski, I. L. Ray-Coquard, A. Cioffi et al., “Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes,” Lancet Oncology, vol. 12, no. 11, pp. 1045–1052, 2011. View at Publisher · View at Google Scholar · View at Scopus
  83. R. G. Maki, “Eribulin in soft-tissue sarcomas,” Lancet Oncology, vol. 12, no. 11, pp. 988-989, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. E. K. Rowinsky and R. C. Donehower, “The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics,” Pharmacology & Therapeutics, vol. 52, no. 1, pp. 35–84, 1991. View at Publisher · View at Google Scholar · View at Scopus
  85. M. L. Hensley, R. Maki, E. Venkatraman et al., “Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial,” Journal of Clinical Oncology, vol. 20, no. 12, pp. 2824–2831, 2002. View at Publisher · View at Google Scholar · View at Scopus
  86. K. M. Leu, L. J. Ostruszka, D. Shewach et al., “Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma,” Journal of Clinical Oncology, vol. 22, no. 9, pp. 1706–1712, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. J. O. Bay, I. Ray-Coquard, J. Fayette et al., “Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis,” International Journal of Cancer, vol. 119, no. 3, pp. 706–711, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. R. T. Kurmasheva, L. Dudkin, C. Billups, L. V. Debelenko, C. L. Morton, and P. J. Houghton, “The insulin-like growth factor-1 receptor-targeting antibody, CP-751,871, suppresses tumor-derived VEGF and synergizes with rapamycin in models of childhood sarcoma,” Cancer Research, vol. 69, no. 19, pp. 7662–7671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. A. Naing, P. LoRusso, S. Fu et al., “Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing’s sarcoma family tumors,” Clinical Cancer Research, vol. 18, no. 9, pp. 2625–2631, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. S. P. D’Angelo, A. N. Shoushtari, N. P. Agaram et al., “PD-L1 expression and immune infiltrates in sarcoma,” Journal of Clinical Oncology, vol. 32, no. 15, p. 10522, 2014. View at Publisher · View at Google Scholar
  91. S. Modak, W. Gerald, and N. K. Cheung, “Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor,” Medical and Pediatric Oncology, vol. 39, no. 6, pp. 547–551, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. W. D. Tap, G. Demetri, P. Barnette et al., “Phase II study of Ganitumab, a fully human anti–type-1 insulin-like growth factor receptor antibody, in patients with metastatic Ewing family tumors or desmoplastic small round cell tumors,” Journal of Clinical Oncology, vol. 30, no. 15, pp. 1849–1856, 2016. View at Publisher · View at Google Scholar
  93. S. P. D’Angelo, A. N. Shoushtari, N. P. Agaram et al., “Prevalence of tumor infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment,” Human Pathology, vol. 46, no. 3, pp. 357–365, 2015. View at Publisher · View at Google Scholar · View at Scopus
  94. H. D. Magnan, T. Chou, M. P. LaQuaglia, W. Gerald, M. Ladanyi, and M. S. Merchant, “Elevated expression of VEGFR-2 and VEGFA in desmoplastic small round cell tumor (DSRCT) and activity of bevacizumab and irinotecan in a xenograft model of DSRCT,” Journal of Clinical Oncology, vol. 27, no. 15, p. 20, 2016. View at Google Scholar
  95. H. D. Magnan, A. Price, A. J. Chou et al., “A pilot trial of irinotecan, temozolomide and bevacizumab (ITB) for treatment of newly diagnosed patients with desmoplastic small round cell tumor (DSRCT),” July 2017. View at Google Scholar
  96. N. B. Desai, N. F. Stein, M. P. LaQuaglia et al., “Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience,” International Journal of Radiation Oncology, Biology, Physics, vol. 85, no. 1, pp. e67–e72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. E. M. Osborne, T. M. Briere, and A. Hayes-Jordan, “Survival and toxicity following sequential multimodality treatment including whole abdominopelvic radiotherapy for patients with desmoplastic small round cell tumor,” Radiotherapy and Oncology, vol. 119, no. 1, pp. 40–44, 2017. View at Publisher · View at Google Scholar · View at Scopus
  98. H. H. Wong, H. M. Hatcher, C. Benson et al., “Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature,” Clinical Sarcoma Research, vol. 3, no. 1, p. 14, 2013. View at Publisher · View at Google Scholar